Antioxidant vitamins supplementation reduce endometriosis related pelvic pain in humans: a systematic review and meta-analysis

Reproductive Biology and Endocrinology

Review

Yi Chen¹  Xian-Qian Chen¹  Sai-Hua Zheng¹  Xiu-Xia Chen¹  Zhi-Cong Wu¹  Xue-Lian Li² 

[1] Gynaecology Department, The First Hospital of PuTian City, 351100, Putian, Fujian, China;Obstetrics and Gynecology Hospital, Fudan University, 200011, Shanghai, People’s Republic of China;Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital, Fudan University, 200011, Shanghai, People’s Republic of China;Shanghai Clinical Research Center for Gynecological Diseases (22MC1940200), Shanghai Urogenital System Diseases Research Center (2022ZZ01012), 200011, Shanghai, People’s Republic of China;

关键词: Vitamin E;    Vitamin C;    Vitamin D;    Antioxidant;    Supplementation;    Pain;    Endometriosis;   

DOI  :  10.1186/s12958-023-01126-1

 received in 2023-06-07, accepted in 2023-08-10,  发布年份 2023

来源: Springer

【 摘 要 】

ObjectiveThis study aimed to clarify the effect of antioxidant vitamins supplementation on endometriosis-related pain.MethodsA systematic search of PubMed, Web of Science, Cochrane Library, Scopus, and China National Knowledge Infrastructure (CNK) databases was conducted to identify relevant studies published in English and Chinese up to 16 March 2023. The search terms used were "endometriosis" OR "endometrioma" OR "endometrium" AND "antioxidant" OR "Vitamin C" OR "Vitamin E" OR "Vitamin D" OR "25-OHD" OR "25(OH)D" OR "25-hydroxyvitamin D". Eligible studies were randomized controlled trials (RCTs) that assessed pain scores using the Visual Analogue Scale (VAS). Mean differences or odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to evaluate the effect of antioxidant vitamins supplementation on endometriosis. The quality of the included studies was assessed using the Cochrane Risk of Bias Tool. The study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines.ResultsA total of 13 RCTs involving 589 patients were included in this meta-analysis. We identified 11 studies that evaluated the effect of antioxidant vitamins supplementation on endometriosis-related pain. The results indicated that the supplementation of antioxidant vitamins can effectively alleviate endometriosis-related pain. Subgroup analysis showed that the supplementation of vitamin E (with or without vitamin C) had a positive effect on improving clinical pelvic pain in patients with chronic pelvic pain. Conversely, supplementation of vitamin D was associated with a reduction in pelvic pain in endometriosis patients, but the difference was not statistically significant compared to the placebo. Additionally, we observed changes in oxidative stress markers following vitamin supplementation. Plasma malondialdehyde (MDA) concentration decreased in patients with endometriosis after antioxidant vitamin supplementation, and the plasma MDA level was inversely correlated with the time and dose of vitamin E and C supplementation. Furthermore, the inflammatory markers in peritoneal fluid, including RANTES, interleukin-6, and monocyte chemoattractant protein-1, significantly decreased after antioxidant therapy. These findings suggest that antioxidant vitamins may alleviate pain in endometriosis patients by reducing inflammation.ConclusionsThe included studies support the potential role of antioxidant vitamins in the management of endometriosis. Supplementation with antioxidant vitamins effectively reduced the severity of dysmenorrhea, improved dyspareunia and pelvic pain, and enhanced quality of life in these patients. Therefore, antioxidant vitamin therapy could be considered as an alternative treatment method, either alone or in combination with other approaches, for endometriosis-related pain.Trial registrationPROSPERO registration number: CRD42023415198.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023

【 图 表 】

Fig. 5

Fig. 3

Fig. 1

Fig. 2

40708_2023_198_Article_IEq16.gif

Fig. 3

Fig. 2

Fig. 2

Fig. 1

12888_2023_5113_Article_IEq4.gif

40517_2023_261_Article_IEq43.gif